SCOPUS 정보 검색 플랫폼

Volumn 85, Issue 1, 2002, Pages 71-80

Systematic review of first-line chemotherapy for newly diagnosed postoperative patients with stage II, III, or IV epithelial ovarian cancer

(6) Covens, Allan a Carey, Mark b Bryson, Peter c Verma, Shailendra d Fung Kee Fung, Michael d Johnston, Mary e

a UNIVERSITY OF TORONTO (Canada)

b UNIVERSITY OF WESTERN ONTARIO (Canada)

c QUEEN S UNIVERSITY (Canada)

d UNIVERSITY OF OTTAWA (Canada)

e CANCER CARE ONTARIO (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; PACLITAXEL; PLATINUM DERIVATIVE;

BONE MARROW TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDUCED DISEASE; GYNECOLOGIC CANCER; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; MULTICENTER STUDY; NEUROTOXICITY; OVARY CANCER; POSTOPERATIVE CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME;

EID: 0036222963 PISSN: 00908258 EISSN: None Source Type: Journal
DOI: 10.1006/gyno.2001.6552 Document Type: Article

Times cited : (126)

References (34)

1
- 0030054309
- Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
- (1996) N Engl J Med , vol.334 , pp. 1-6
- McGuire, W.P.¹ Hoskins, W.J.² Brady, M.F.³ Kucera, P.R.⁴ Partridge, E.E.⁵ Look, K.Y.⁶ Clarke-Pearson, D.L.⁷ Davidson, M.⁸

2
- 0033986363
- Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage II or IV ovarian cancer: A Gynecologic Oncology Group study
- (2000) J Clin Oncol , vol.18 , pp. 106-115
- Muggia, F.M.¹ Braly, P.S.² Brady, M.F.³ Sutton, G.⁴ Neimann, T.H.⁵ Lentz, S.L.⁶ Alvarez, R.D.⁷ Kucera, P.R.⁸ Small, J.M.⁹

3
- 0034600305
- Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: Three-year results
- (2000) J Natl Cancer Inst , vol.92 , pp. 699-708
- Piccart, M.J.¹ Bertelsen, K.² James, K.³ Cassidy, J.⁴ Mangioni, C.⁵ Simonsen, E.⁶ Stuart, G.⁷ Kaye, S.⁸ Vergote, I.⁹ Blom, R.¹⁰ Grimshaw, R.¹¹ Atkinson, R.J.¹² Swenerton, K.D.¹³ Trope, C.¹⁴ Nardi, M.¹⁵ Kaern, J.¹⁶ Tumolo, S.¹⁷ Timmers, P.¹⁸ Roy, J.A.¹⁹ Lhoas, F.²⁰ more..

4
- 0002324260
- Preliminary results of the SCOTROC trial: A phase III comparison of paclitaxel-carboplatin (PC) and docetaxel-carboplatin (DC) as first-line chemotherapy for stage Ic-IV epithelial ovarian cancer (EOC)
- (2001) Proc Am Soc Clin Oncol , vol.20
- Vasey, P.¹

5
- 0022992740
- Meta-analysis in clinical trials
- (1986) Controlled Clin Trials , vol.7 , pp. 177-188
- Der Simonian, R.¹ Laird, N.²

6
- 7844240130
- Chemotherapy in advanced ovarian cancer: Four systematic meta-analyses of individual patient data from 37 randomized trials
- (1998) Br J Cancer , vol.78 , pp. 1479-1487

7
- 0008829151
- Chemotherapy in advanced ovarian cancer
- (1999) Cochrane Library , Issue.4

8
- 0025861545
- Cyclophosphamide plus cisplatin versus cyclophosphamide, doxorubicin, and cisplatin chemotherapy of ovarian carcinoma: A meta-analysis
- (1991) J Clin Oncol , vol.9 , pp. 1668-1674

9
- 0006541515
- Randomized trial of paclitaxel and carboplatin versus a control arm of carboplatin or CAP (cyclophosphamide, doxorubicin and cisplatin): The third International Collaborative Ovarian Neoplasm study
- (2000) Proc Am Soc Clin Oncol , vol.19
- Colombo, N.¹

10
- 0346423733
- Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer
- (1996) N Engl J Med , vol.335 , pp. 1950-1955
- Alberts, D.S.¹ Liu, P.Y.² Hannigan, E.V.³ O'Toole, R.⁴ Williams, S.D.⁵ Young, J.A.⁶ Franklin, E.W.⁷ Clarke-Pearson, D.L.⁸ Malviya, V.K.⁹ DuBeshter, B.¹⁰

11
- 0032967753
- A comparative study of intraperitoneal carboplatin versus intravenous carboplatin with intravenous cyclophosphamide in both arms as initial chemotherapy for stage III ovarian cancer
- (1999) Oncology , vol.56 , pp. 291-296
- Polyzos, A.¹ Tsavaris, N.² Kosmas, C.³ Giannikos, L.⁴ Katsikas, M.⁵ Kalahanis, N.⁶ Karatzas, G.⁷ Christodoulou, K.⁸ Giannakopoulos, K.⁹ Stamatiadis, D.¹⁰ Katsilambros, N.¹¹

12
- 0000012867
- Cisplatin/paclitaxel vs carboplatin/paclitaxel in ovarian cancer: Update of an Arbeitgemeinschaft Gynaekologische Onkologie (AGO) Study Group trial
- (1999) Proc Am Soc Clin Oncol , vol.18
- Du Bois, A.¹ Lueck, H.J.² Meier, W.³ Moebus, V.⁴ Costa, S.D.⁵ Bauknecht, T.⁶ Richter, B.⁷ Warm, M.⁸ Schroeder, W.⁹ Olbricht, S.¹⁰ Nitz, U.¹¹ Jackisch, C.¹²

13
- 0032517581
- ICON2: Randomized trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin, and cisplatin) in women with ovarian cancer
- (1998) Lancet , vol.352 , pp. 1571-1576

14
- 0033850178
- Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer
- (2000) J Clin Oncol , vol.18 , pp. 3084-3092
- Neijt, J.P.¹ Engelholm, S.A.² Tuxen, M.K.³ Sorensen, P.G.⁴ Hansen, M.⁵ Sessa, C.⁶ De Swart, C.A.⁷ Hirsch, F.R.⁸ Lund, B.⁹ Van Houwelingen, H.C.¹⁰

15
- 0035865144
- Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: An intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group
- (2001) J Clin Oncol , vol.19 , pp. 1001-1007
- Markman, M.¹ Bundy, B.N.² Alberts, D.S.³ Fowler, J.M.⁴ Clark-Pearson, D.L.⁵ Carson, L.F.⁶ Wadler, S.⁷ Sickel, J.⁸

16
- 0026032160
- Carboplatin, doxorubicin, and cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide: A randomized trial in stage III-IV epithelial ovarian carcinoma
- (1991) J Clin Oncol , vol.9 , pp. 658-663
- Conte, P.F.¹ Bruzzone, M.² Carnino, F.³ Chiara, S.⁴ Donadio, M.⁵ Facchini, V.⁶ Fioretti, P.⁷ Foglia, G.⁸ Gadducci, A.⁹ Gallo, L.¹⁰ Giaccone, G.¹¹ Guercio, E.¹² Iskra, L.¹³ Janssen, N.¹⁴ Maresi, M.P.¹⁵ Parodi, G.¹⁶ Ragni, N.¹⁷ Rosso, R.¹⁸ Rubagotti, A.¹⁹ Rugiati, S.²⁰ more..

17
- 0024465181
- Randomized trial in advanced ovarian cancer comparing cisplatin and carboplatin
- (1989) J Natl Cancer Inst , vol.81 , pp. 1464-1471
- Mangioni, C.¹ Bolis, G.² Pecorelli, S.³ Bragman, K.⁴ Epis, A.⁵ Favalli, G.⁶ Gambino, A.⁷ Landoni, F.⁸ Presti, M.⁹ Torri, W.¹⁰ Vessena, L.¹¹ Zanaboni, F.¹² Marsoni, S.¹³

18
- 0024598398
- A comparison of the toxicity and efficacy of cisplatin and carboplatin in advanced ovarian cancer
- (1989) Acta Oncol , vol.28 , pp. 57-60
- Adams, M.¹ Kerby, I.J.² Rocker, I.³ Evans, A.⁴ Johansen, K.⁵ Franks, C.R.⁶

19
- 0026634982
- Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: Final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer
- (1992) J Clin Oncol , vol.10 , pp. 706-717
- Alberts, D.S.¹ Green, S.² Hannigan, E.V.³ O'Toole, R.⁴ Stock-Novack, D.⁵ Anderson, P.⁶ Surwit, E.A.⁷ Malvlya, V.K.⁸ Nahhas, W.A.⁹ Jolles, C.J.¹⁰

20
- 0026763305
- Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: A randomized phase III study of the National Cancer Institute of Canada Clinical Trials Group
- (1992) J Clin Oncol , vol.10 , pp. 718-726
- Swenerton, K.¹ Jeffrey, J.² Stuart, G.³ Roy, M.⁴ Krepart, G.⁵ Carmichael, J.⁶ Drouin, P.⁷ Stanimir, R.⁸ O'Connell, G.⁹ MacLean, G.¹⁰ Kirk, M.E.¹¹ Canetta, R.¹² Koski, B.¹³ Shelley, W.¹⁴ Zee, B.¹⁵ Pater, J.¹⁶

21
- 8544240832
- Randomized study comparing carboplatin/cyclophosphamide and cisplatin/cyclophosphamide as first-line treatment in patients with stage II/IV epithelial ovarian cancer and small volume disease
- (1997) Gynecol Oncol , vol.66 , pp. 75-84
- Meerpohl, H.G.¹ Sauerbrei, W.² Kuhnle, H.³ Schumacher, M.⁴

22
- 85009030130
- Treatment of patients with advanced ovarian cancer (FIGO IIb-IV) with cisplatin/paclitaxel or carboplatin/paclitaxel - An interim analysis of the AGO study protocol OVAR-3
- (1999) Eur J Cancer , vol.35 , Issue.SUPPL. 4
- Schroder, W.¹ Du Bois, A.² Kuhn, W.³ Luck, H.J.⁴ Mobus, V.⁵ Meier, W.⁶ Nitz, S.⁷ Olbricht, J.⁸ Pfisterer, J.⁹

23
- 0000121237
- Randomized phase III study of cisplatin/paclitaxel versus carboplatin/paclitaxel in optimal stage III ovarian cancer: A Gynecologic Oncology Group Trial (GOG 158)
- (1999) Proc Am Soc Clin Oncol , vol.18
- Ozols, R.F.¹ Bundy, B.N.² Fowler, J.³ Clarke-Pearson, D.⁴ Mannel, R.⁵ Hartenbach, E.M.⁶ Baergen, R.⁷

24
- 0023711367
- Carboplatin in combination therapy for ovarian cancer
- (1988) Cancer Treat Rev , vol.15 , Issue.SUPPL. B , pp. 9-15
- Ten Bokkel Huinink, W.W.¹ Van der Burg, M.E.² Van Oosterom, A.T.³ Neijt, J.P.⁴ George, M.⁵ Guastalla, J.P.⁶ Veenhof, C.H.⁷ Rotmensz, N.⁸ Dalesio, O.⁹ Vermorken, J.B.¹⁰

25
- 0008852204
- Cisplatin/paclitaxel vs carboplatin/paclitaxel in ovarian cancer: Results of a prospective randomized phase III study
- (1999) Proc Int Gynecol Cancer Soc , pp. 48
- Meier, W.¹ Du Bois, S.² Olbricht, U.³ Nitz, U.⁴ Jackisch, C.⁵ Richter, B.⁶ Warm, M.⁷ Costa, S.⁸ Luck, H.⁹ Mobus, V.¹⁰ Bauknecht, T.¹¹ Schroder, W.¹²

26
- 85030002257
- Paclitaxel delivered as a 3-hr infusion with cisplatin in patients with gynecologic cancers: Unexpected incidence of neurotoxicity
- (1997) Gynecol Oncol , vol.66 , pp. 338-339
- Connelly, E.¹ Markman, M.² Kennedy, A.³ Webster, K.⁴ Kulp, B.⁵ Peterson, G.⁶ Belinson, J.⁷

27
- 0004644516
- Epirubicin/paclitaxel/carboplatin vs. paclitaxel/carboplatin as first-line treatment in ovarian cancer: Updated results of a safety interim analysis of the AGO-GINECO Intergroup Trial
- (1999) Proc Int Gynecol Cancer Soc , pp. 48
- Mobus, V.¹ Provencal, J.² Du Bois, A.³ Vincent, P.⁴ Luck, H.J.⁵ Combe, M.⁶ Kimmig, R.⁷ Costa, S.⁸

28
- 7144228608
- Randomized trial of dose-intensity with single-agent carboplatin in patients with epithelial ovarian cancer
- (1998) J Clin Oncol , vol.16 , pp. 2426-2434
- Gore, M.¹ Mainwaring, P.² A'Hern, R.³ MacFarlane, V.⁴ Slevin, M.⁵ Harper, P.⁶ Osborne, R.⁷ Mansi, J.⁸ Blake, P.⁹ Wiltshaw, E.¹⁰ Shepherd, J.¹¹

29
- 0031025089
- Dose-effect study of carboplatin in ovarian cancer: A Danish Ovarian Cancer Group study
- (1997) J Clin Oncol , vol.15 , pp. 193-198
- Jakobsen, A.¹ Bertelsen, K.² Andersen, J.E.³ Havsteen, H.⁴ Jakobsen, P.⁵ Moeller, K.A.⁶ Nielsen, K.⁷ Sandberg, E.⁸ Stroeyer, I.⁹

30
- 0028868457
- Meta-analysis comparing cisplatin total dose intensity and survival
- (1995) Gynecol Oncol , vol.59 , pp. 93-101
- Ben-David, Y.¹ Rosen, B.² Franssen, E.³ Einarson, T.⁴ Szyfer, I.⁵

31
- 0027999966
- European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: High-dose versus low-dose and long versus short infusion
- (1994) J Clin Oncol , vol.12 , pp. 2654-2666
- Eisenhauer, E.A.¹ Ten Bokkel Huinink, W.W.² Swenerton, K.D.³ Gianni, L.⁴ Myles, J.⁵ Van der Burg, M.E.⁶ Kerr, I.⁷ Vermorken, J.B.⁸ Buser, K.⁹ Colombo, N.¹⁰

32
- 0030918128
- A randomized trial of five versus eight courses of cisplatin or carboplatin in advanced epithelial ovarian cancer
- (1997) Ann Oncol , vol.8 , pp. 327-333
- Lambert, H.E.¹ Rustin, G.J.S.D.² Gregory, W.M.³ Nelstrop, A.E.⁴

33
- 0026720218
- Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinoma
- (1992) Gynecol Oncol , vol.45 , pp. 284-289
- Hakes, T.B.¹ Chalas, E.² Hoskins, W.J.³ Jones, W.B.⁴ Markman, M.⁵ Rubin, S.C.⁶ Chapman, D.⁷ Almadrones, L.⁸ Lewis Jr., J.L.⁹

34
- 0027276217
- A prospective randomized comparison of 6 and 12 cycles of cyclophosphamide, adriamycin, and cisplatin in advanced epithelial ovarian cancer: A Danish Ovarian Cancer Group study
- (1993) Gynecol Oncol , vol.49 , pp. 30-36
- Bertelsen, K.¹ Jakobsen, A.² Stroyer, J.³ Nielsen, K.⁴ Sandberg, E.⁵ Andersen, J.E.⁶ Ahrons, S.⁷ Nyland, M.⁸ Hjortkjaer Pedersen, P.⁹ Larsen, G.¹⁰ Rasmussen, P.¹¹ Kiaer, H.¹² Bichel, P.¹³ Jacobsen, M.¹⁴ Holund, B.¹⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.